Great Point Partners LLC Chemo Centryx, Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$47.25 - $65.16 $12 Million - $16.5 Million
-253,230 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$46.35 - $61.69 $11.7 Million - $15.6 Million
253,230 New
253,230 $13.9 Million
Q2 2020

Aug 14, 2020
SELL
$38.58 - $65.07 $13.8 Million - $23.3 Million
-357,379 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$32.73 - $50.78 $11.7 Million - $18.1 Million
357,379 New
357,379 $14.4 Million

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email